Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 Dec;14(12):1323–1333. doi: 10.1016/j.bbmt.2008.09.008

Figure 2.

Figure 2

Cumulative incidence of treatment-related mortality (TRM) and relapse after autologous HCTs for follicular grade III/diffuse large B cell/immunoblastic NHL patients age < 55 years versus ≥ 55 years.